IndraLab

Statements

Cisplatin activates KCNH1. 1 / 1

| 1

reach

"However, the relationship of Eag1 expression with the clinical outcome of patients having ovarian cancer treated with cisplatin based adjuvant chemotherapy is still unknown."

26079730

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Cisplatin activates KCNH1. 1 / 1

INDRA sources:

Databases

Reading